NASDAQ:SRNE
Delisted
Sorrento Therapeutics Stock News
$0.307
+0 (+0%)
At Close: Feb 23, 2023
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders
03:48am, Sunday, 05'th Feb 2023 GlobeNewswire Inc.
PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a
SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent
Sorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
07:12pm, Thursday, 02'nd Feb 2023 GlobeNewswire Inc.
SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questions” document u
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
06:15pm, Thursday, 02'nd Feb 2023 GlobeNewswire Inc.
PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today
Sorrento Issues “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
03:27am, Monday, 30'th Jan 2023 GlobeNewswire Inc.
SAN DIEGO, Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a “Frequently Asked Questions” document under the “Investors” section of
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock
02:55am, Monday, 30'th Jan 2023 GlobeNewswire Inc.
PALO ALTO, Calif., Jan. 29, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
08:56pm, Thursday, 26'th Jan 2023 Benzinga
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this
Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
06:11pm, Tuesday, 24'th Jan 2023 Benzinga
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in
3M, Magna International And Other Big Stocks Moving Lower On Tuesday
03:59pm, Tuesday, 24'th Jan 2023 Benzinga
U.S. stocks traded mostly higher, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording losses in today’s session.
Satixfy Communications Ltd. (NASDAQ: SATX) sha
A SPAC, Spinoff, And Short Squeeze Walk Into A Bar
03:30pm, Tuesday, 24'th Jan 2023
Shares of Scilex could trade higher due to hedging pressure from large Sorrento short positions. Scilex's equity offering facilities, mean that the price could fall precipitously at any time via compa
Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
12:46pm, Friday, 13'th Jan 2023
Sorrento Therapeutics is on the move following preliminary results from its subsidiary Scilex. Scilex is making money with the company's 1st product to market
Sorrento Releases Positive Results from a Phase 1b Study in China in COVID-19 Patients and is Ready for Pivotal Phase 3 trials with OVYDSO™ (STI-1558), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19 without the Need for Ritonavir Boosting
02:00pm, Monday, 09'th Jan 2023 GlobeNewswire Inc.
SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today released unblinded Phase 1b study data of its oral main viral protease (Mpro) inhibito
Macy's, DoorDash And Some Other Big Stocks Moving Lower In Monday's Pre-Market Session
11:19am, Monday, 09'th Jan 2023 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Moolec Science SA (NASDAQ: MLEC) shares dropped 28.4% to $13.78 in p
Biggest Penny Stocks Trading Mistakes to Avoid in 2023
11:00am, Wednesday, 04'th Jan 2023 PennyStocks
Avoid making these penny stocks trading mistakes this year
The post Biggest Penny Stocks Trading Mistakes to Avoid in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Biggest Penny Stocks Trading Mistakes to Avoid in 2023
06:00am, Wednesday, 04'th Jan 2023
Avoid making these penny stocks trading mistakes this year The post Biggest Penny Stocks Trading Mistakes to Avoid in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
